Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-01

Clinical Trial Update: Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for neoadjuvant chemotherapy with PISOXO in locally invaded gastric cancer spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PISOXO

Snippet

Sponsor: Ruijin Hospital | Conditions: Stomach Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN